Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

The immunogenicity of the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccine was improved by the administration of a third dose. The aim of our retrospective study was to assess the evolution of binding and neutralizing antibody concentration until 3 months after the third dose in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamar, Nassim, Abravanel, Florence, Marion, Olivier, Esposito, Laure, Hebral, Anne Laure, Médrano, Chloé, Guitard, Joelle, Lavayssière, Laurence, Cointault, Olivier, Nogier, Marie Bétriace, Bellière, Julie, Faguer, Stanislas, Couat, Chloé, Del Bello, Arnaud, Izopet, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149234/
https://www.ncbi.nlm.nih.gov/pubmed/35000296
http://dx.doi.org/10.1111/ajt.16950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149234/
https://www.ncbi.nlm.nih.gov/pubmed/35000296
http://dx.doi.org/10.1111/ajt.16950

Ejemplares similares